Blog
Clinical Trial Industry will be transformed by a new emphasis on patients and data
Three factors could vastly transform the clinical research industry as we know it. The three factors include: the patient engagement movement, rich data and analytics, and the learning health system model, reported CenterWatch.1 Ken Getz, an industry...
MAGI’s Clinical Research Conference will feature Patti Connolly
Patti Connolly, Director of Clinical Services at Pearl Pathways, is a featured speaker at MAGI's Clinical Research Conference - 2018 East. MAGI is an organization that aims to streamline clinical research by standardizing best practices for...
Robert Seevers will speak about Good Distribution Practices to the Consumer Healthcare Products Association
Robert Seevers, Senior Advisor and Adjunct Board Member at Pearl IRB, will travel to Washington, DC May 17-18, 2018 to speak about Good Distribution Practices (GDP). Seevers will speak to the Consumer Healthcare Products Association (CHPA) on behalf of the...
Diana Caldwell, Gretchen Bowker to deliver IRB presentation for JLABS at TMC
Pearl IRB co-founders, Diana Caldwell and Gretchen Bowker, have been invited to speak at the Johnson & Johnson Innovation center at the Texas Medical Center, also known as JLABS @ TMC. Bowker and Caldwell will speak to startup medical...
FDA expands guidance on pediatric clinical trials with new ICH E11(R1) Addendum
The United Stated Food and Drug Administration (FDA) implemented its version of the International Council for Harmonization’s (ICH) addendum on pediatric clinical trials and drug development, RAPS reports.¹ FDA added a considerable amount of new...